NEWS

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on November 5th, 2018 in Boston, MA. In today's ...

After last year´s success, we take pleasure to inform you that ARENSIA is organizing the 2nd Workshop focused on “Practical Insights and future visions to maximize efficiency in PROOF OF CONCEPT patient trials”. Industry leaders ...

We are pleased to announce ARENSIA Innovative Spotlight Session "Practical Insights and Future Visions to maximize Efficiency in Proof-Of-Concept Patient Trials", which will take place on 16th May 2018 in San Francisco, CA. In today'...

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 7th November 2017 in Boston, MA. In today's fast-changing world, ...

As consequence of the increasing demand for ARENSIA´s capabilities as a specialist for early clinical trials in patients, as of August 2017, ARENSIA expands its operations with a new clinical research unit in Kiev, Ukraine. Ukraine (45 Mio. ...

We are pleased to announce ARENSIA Spotlight Session "Innovative Strategies to Achieve First Efficacy Data / Proof-of-Concept in Record Time", which will take place on 24th May 2017 in San Francisco, CA. In today's fast-changing worl...

At ARENSIA, we are looking back on a very good business year, in which we were able to outdo ourselves with regard to outstanding patient enrolment rates in complex Phase 1, 2a, POC studies at our Phase 1 units in Eastern Europe. Studies involved sop...

As of August 2015, ARENSIA expands its operations with a new clinical research unit in Bucharest, Romania. This unit is fully dedicated to exploratory clinical trials Phase 1 and 2 in PEDIATRIC patients (age 0-18) with chronic and acute conditions...